Daunomycin inhibits the B leads to Z transition in poly d(G-C).

AUTOR(ES)

Chaires, J B

RESUMO

The cancer drug daunomycin is an effective inhibitor of the B leads to Z transition in poly d(G-C) in 4 M NaCl. Both the rate and extent of the B leads to Z transition are decreased by the drug, as judged by equilibrium and kinetic studies. Daunomycin can, under some conditions, convert Z form DNA back to B form. Drug binding to poly d(G-C) in 4 M NaCl is slow and highly cooperative, consistent with a role for daunomycin as an allosteric effector on the B leads to Z equilibrium. Since daunomycin binds preferentially to alternating purine-pyrimidine sequences, which are the very sequences capable of undergoing the B leads to Z transition, these effects may be an important part of the mechanism by which the drug inhibits transcription and replication.

Documentos Relacionados

• Thermodynamics of the B to Z transition in poly(m5dG-dC).
• Energetics of Z-DNA formation in poly d(A-T), poly d(G-C), and poly d(A-C) poly d(G-T).
• The B goes to Z transition of poly(dG-dC) . poly(dG-dC) modified by some platinum derivatives.
• Binding of [(dien)PtCl] Cl to poly(dG-dC)-poly(dG-dC) facilitates the B goes to Z conformational transition.
• Effect of the B--Z transition in poly(dG-m5dC) . poly(dG-m5dC) on nucleosome formation.